Research Options:
Week of Expected Pricing Withdrawn
Company Name Dance Biopharm, Inc.
Proposed Ticker DNCE
CUSIP N/A
Business Description A biopharmaceutical company focused on the development of inhaled insulin products for the treatment of diabetes.
Lead Underwriter Stifel Nicolaus & Company, Incorporated Wells Fargo Securities, LLC.
Co-Managers Oppenheimer and Co., Inc, Roth Capital Partners, Inc.
Initial Shares N/A
Revised Initial Shares N/A
Initial Price N/A
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.